Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.58750274 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.58750274 |
3 | aromatic amino acid family catabolic process (GO:0009074) | 6.32745766 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.24117479 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.24117479 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.16744942 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.16744942 |
8 | tryptophan catabolic process (GO:0006569) | 6.16744942 |
9 | tryptophan metabolic process (GO:0006568) | 5.82553120 |
10 | kynurenine metabolic process (GO:0070189) | 5.61162848 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.48638971 |
12 | urea cycle (GO:0000050) | 5.37211965 |
13 | urea metabolic process (GO:0019627) | 5.37211965 |
14 | bile acid biosynthetic process (GO:0006699) | 5.26797016 |
15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21713240 |
16 | protein carboxylation (GO:0018214) | 5.05379481 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05379481 |
18 | homocysteine metabolic process (GO:0050667) | 4.99186394 |
19 | nitrogen cycle metabolic process (GO:0071941) | 4.87749998 |
20 | response to pheromone (GO:0019236) | 4.79849998 |
21 | glyoxylate metabolic process (GO:0046487) | 4.74903545 |
22 | imidazole-containing compound metabolic process (GO:0052803) | 4.73718949 |
23 | amino-acid betaine metabolic process (GO:0006577) | 4.72052566 |
24 | complement activation, alternative pathway (GO:0006957) | 4.70698430 |
25 | regulation of protein activation cascade (GO:2000257) | 4.66429735 |
26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61349020 |
27 | phospholipid efflux (GO:0033700) | 4.60029466 |
28 | sulfur amino acid catabolic process (GO:0000098) | 4.58324635 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 4.56667512 |
30 | indolalkylamine metabolic process (GO:0006586) | 4.54812964 |
31 | bile acid metabolic process (GO:0008206) | 4.53449698 |
32 | reverse cholesterol transport (GO:0043691) | 4.44714335 |
33 | negative regulation of fibrinolysis (GO:0051918) | 4.43121014 |
34 | cysteine metabolic process (GO:0006534) | 4.42004541 |
35 | regulation of triglyceride catabolic process (GO:0010896) | 4.39298082 |
36 | regulation of fibrinolysis (GO:0051917) | 4.37955555 |
37 | serine family amino acid catabolic process (GO:0009071) | 4.37179090 |
38 | regulation of complement activation (GO:0030449) | 4.36042927 |
39 | alpha-linolenic acid metabolic process (GO:0036109) | 4.32665954 |
40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32451999 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.32451999 |
42 | macromolecular complex remodeling (GO:0034367) | 4.32451999 |
43 | molting cycle (GO:0042303) | 4.32055643 |
44 | hair cycle (GO:0042633) | 4.32055643 |
45 | amine catabolic process (GO:0009310) | 4.29149565 |
46 | cellular biogenic amine catabolic process (GO:0042402) | 4.29149565 |
47 | DNA deamination (GO:0045006) | 4.24984307 |
48 | behavioral response to nicotine (GO:0035095) | 4.23945950 |
49 | triglyceride homeostasis (GO:0070328) | 4.23429864 |
50 | acylglycerol homeostasis (GO:0055090) | 4.23429864 |
51 | tyrosine metabolic process (GO:0006570) | 4.18574197 |
52 | regulation of cholesterol esterification (GO:0010872) | 4.11194223 |
53 | negative regulation of cholesterol transport (GO:0032375) | 4.09999522 |
54 | negative regulation of sterol transport (GO:0032372) | 4.09999522 |
55 | fibrinolysis (GO:0042730) | 4.09475557 |
56 | fucose catabolic process (GO:0019317) | 3.98050680 |
57 | L-fucose metabolic process (GO:0042354) | 3.98050680 |
58 | L-fucose catabolic process (GO:0042355) | 3.98050680 |
59 | alpha-amino acid catabolic process (GO:1901606) | 3.97788511 |
60 | platelet dense granule organization (GO:0060155) | 3.97649880 |
61 | bile acid and bile salt transport (GO:0015721) | 3.96657189 |
62 | linoleic acid metabolic process (GO:0043651) | 3.96285685 |
63 | coenzyme catabolic process (GO:0009109) | 3.90107594 |
64 | cholesterol efflux (GO:0033344) | 3.85230678 |
65 | establishment of skin barrier (GO:0061436) | 3.80164083 |
66 | keratinization (GO:0031424) | 3.79497781 |
67 | plasma lipoprotein particle clearance (GO:0034381) | 3.79380379 |
68 | NAD biosynthetic process (GO:0009435) | 3.77762136 |
69 | urate metabolic process (GO:0046415) | 3.77502845 |
70 | cellular glucuronidation (GO:0052695) | 3.77322543 |
71 | carnitine metabolic process (GO:0009437) | 3.76701648 |
72 | lysine metabolic process (GO:0006553) | 3.74752942 |
73 | lysine catabolic process (GO:0006554) | 3.74752942 |
74 | negative regulation of lipase activity (GO:0060192) | 3.73571300 |
75 | drug catabolic process (GO:0042737) | 3.73073080 |
76 | arginine metabolic process (GO:0006525) | 3.63832779 |
77 | benzene-containing compound metabolic process (GO:0042537) | 3.62283367 |
78 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59813037 |
79 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59813037 |
80 | cellular amino acid catabolic process (GO:0009063) | 3.59242207 |
81 | glutamate metabolic process (GO:0006536) | 3.55663612 |
82 | plasma lipoprotein particle assembly (GO:0034377) | 3.54293533 |
83 | cellular ketone body metabolic process (GO:0046950) | 3.54181141 |
84 | negative regulation of interleukin-1 production (GO:0032692) | 3.53944926 |
85 | complement activation (GO:0006956) | 3.52117367 |
86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.50429604 |
87 | phospholipid homeostasis (GO:0055091) | 3.50329673 |
88 | drug transmembrane transport (GO:0006855) | 3.50185314 |
89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47221013 |
90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47221013 |
91 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.45647471 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.45282251 |
93 | cofactor catabolic process (GO:0051187) | 3.41828610 |
94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.40760245 |
95 | cellular modified amino acid catabolic process (GO:0042219) | 3.40130000 |
96 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.37812166 |
97 | protein activation cascade (GO:0072376) | 3.36950427 |
98 | cholesterol homeostasis (GO:0042632) | 3.36947982 |
99 | complement activation, classical pathway (GO:0006958) | 3.35920279 |
100 | plasma lipoprotein particle organization (GO:0071827) | 3.35800322 |
101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.35110081 |
102 | aldehyde catabolic process (GO:0046185) | 3.31393325 |
103 | sterol homeostasis (GO:0055092) | 3.31052855 |
104 | glucuronate metabolic process (GO:0019585) | 3.29919563 |
105 | uronic acid metabolic process (GO:0006063) | 3.29919563 |
106 | serine family amino acid metabolic process (GO:0009069) | 3.29340841 |
107 | positive regulation of lipid catabolic process (GO:0050996) | 3.28758438 |
108 | desmosome organization (GO:0002934) | 3.28459169 |
109 | exogenous drug catabolic process (GO:0042738) | 3.28347382 |
110 | regulation of memory T cell differentiation (GO:0043380) | 3.10324941 |
111 | positive regulation of defense response to virus by host (GO:0002230) | 3.06199085 |
112 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.98344985 |
113 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.87563395 |
114 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85142456 |
115 | cytidine metabolic process (GO:0046087) | 2.84569217 |
116 | cytidine catabolic process (GO:0006216) | 2.84569217 |
117 | cytidine deamination (GO:0009972) | 2.84569217 |
118 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82634804 |
119 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82634804 |
120 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.78213253 |
121 | positive regulation of prostaglandin secretion (GO:0032308) | 2.77113056 |
122 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.76188606 |
123 | negative regulation of mast cell activation (GO:0033004) | 2.74504225 |
124 | adaptation of signaling pathway (GO:0023058) | 2.71220479 |
125 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.69784524 |
126 | neural tube formation (GO:0001841) | 2.64990395 |
127 | piRNA metabolic process (GO:0034587) | 2.63344771 |
128 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.59951339 |
129 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.59698455 |
130 | negative regulation of telomere maintenance (GO:0032205) | 2.59291531 |
131 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.57880369 |
132 | inositol phosphate catabolic process (GO:0071545) | 2.54028664 |
133 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.52971562 |
134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.50216330 |
135 | polyol catabolic process (GO:0046174) | 2.49206209 |
136 | indole-containing compound metabolic process (GO:0042430) | 2.49106001 |
137 | photoreceptor cell maintenance (GO:0045494) | 2.49010094 |
138 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.48112276 |
139 | interferon-gamma production (GO:0032609) | 2.45070380 |
140 | rRNA catabolic process (GO:0016075) | 2.43507156 |
141 | positive regulation of fatty acid transport (GO:2000193) | 2.43460054 |
142 | neutrophil mediated immunity (GO:0002446) | 2.42961968 |
143 | neutrophil activation (GO:0042119) | 2.40851468 |
144 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.40676750 |
145 | respiratory chain complex IV assembly (GO:0008535) | 2.40100816 |
146 | axoneme assembly (GO:0035082) | 2.39408160 |
147 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.38144330 |
148 | protein polyglutamylation (GO:0018095) | 2.37539532 |
149 | regulation of heat generation (GO:0031650) | 2.37164178 |
150 | cell wall macromolecule catabolic process (GO:0016998) | 2.36338432 |
151 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.34799704 |
152 | regulation of glucokinase activity (GO:0033131) | 2.34158803 |
153 | regulation of hexokinase activity (GO:1903299) | 2.34158803 |
154 | mast cell activation (GO:0045576) | 2.33949186 |
155 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33916136 |
156 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.32443432 |
157 | protein K11-linked deubiquitination (GO:0035871) | 2.30428495 |
158 | positive regulation of heat generation (GO:0031652) | 2.29837621 |
159 | cellular response to interleukin-15 (GO:0071350) | 2.29823443 |
160 | retinal cone cell development (GO:0046549) | 2.28883383 |
161 | regulation of defense response to virus by host (GO:0050691) | 2.28237550 |
162 | magnesium ion transport (GO:0015693) | 2.27934023 |
163 | negative regulation of interleukin-12 production (GO:0032695) | 2.27045501 |
164 | DNA methylation involved in gamete generation (GO:0043046) | 2.25711252 |
165 | inositol phosphate dephosphorylation (GO:0046855) | 2.25528661 |
166 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.25528661 |
167 | arginine catabolic process (GO:0006527) | 2.24088901 |
168 | nitric oxide mediated signal transduction (GO:0007263) | 2.22573568 |
169 | positive regulation of organic acid transport (GO:0032892) | 2.22562216 |
170 | DNA demethylation (GO:0080111) | 2.20939726 |
171 | superoxide anion generation (GO:0042554) | 2.20663278 |
172 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.20511144 |
173 | protein complex biogenesis (GO:0070271) | 2.19590487 |
174 | ketone body metabolic process (GO:1902224) | 2.19380696 |
175 | regulation of action potential (GO:0098900) | 2.18881047 |
176 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.18699648 |
177 | regulation of cilium movement (GO:0003352) | 2.18057200 |
178 | mannosylation (GO:0097502) | 2.17767559 |
179 | multicellular organism reproduction (GO:0032504) | 2.17759343 |
180 | mast cell degranulation (GO:0043303) | 2.17398762 |
181 | mast cell activation involved in immune response (GO:0002279) | 2.17398762 |
182 | positive regulation of mast cell activation (GO:0033005) | 2.17237063 |
183 | response to interferon-beta (GO:0035456) | 2.16168140 |
184 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.15996082 |
185 | cornea development in camera-type eye (GO:0061303) | 2.15932593 |
186 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.14620780 |
187 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.14137369 |
188 | epithelial cilium movement (GO:0003351) | 2.13972314 |
189 | synaptic transmission, cholinergic (GO:0007271) | 2.13736664 |
190 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.13638971 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.51973677 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.38631789 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.35285182 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.43821752 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.94025741 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33522351 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.09443829 |
8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.03578635 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.97350650 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.13590615 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87523692 |
12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.86116739 |
13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.79399177 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54738303 |
15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50998848 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.16919511 |
17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15343199 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00543681 |
19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97013749 |
20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.95986867 |
21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95253232 |
22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.92524710 |
23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85969455 |
24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84997370 |
25 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.77889959 |
26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.77228466 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76803901 |
28 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.74608366 |
29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73508591 |
30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71037806 |
31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71016948 |
32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68393795 |
33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67225851 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62177105 |
35 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.62065124 |
36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56529576 |
37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55662812 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48255833 |
39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45514268 |
40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43339291 |
41 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42957103 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42874593 |
43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42647430 |
44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42581013 |
45 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40606554 |
46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38199582 |
47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36274656 |
48 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35433481 |
49 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35433481 |
50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34792801 |
51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33894587 |
52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33641680 |
53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33641680 |
54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31366562 |
55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30773061 |
56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30726841 |
57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30726841 |
58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.28978715 |
59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28702970 |
60 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.27445941 |
61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26221317 |
62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25089855 |
63 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24833727 |
64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23586708 |
65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23586708 |
66 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.23364196 |
67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22907926 |
68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22442725 |
69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.22169074 |
70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21088206 |
71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20681571 |
72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20650247 |
73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20264162 |
74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20010817 |
75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18009505 |
76 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17773337 |
77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16878776 |
78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16851747 |
79 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15214828 |
80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14485788 |
81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14473221 |
82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12446875 |
83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11865389 |
84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11675786 |
85 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11508193 |
86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11202827 |
87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10253100 |
88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09545314 |
89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08801399 |
90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08735684 |
91 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08148147 |
92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07026816 |
93 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06619612 |
94 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.06506779 |
95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06000819 |
96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05822423 |
97 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04781153 |
98 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04356775 |
99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03441512 |
100 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03061447 |
101 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.02933992 |
102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02770457 |
103 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02571620 |
104 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02306028 |
105 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02267135 |
106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01926724 |
107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01804931 |
108 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01406881 |
109 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00804159 |
110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.00489760 |
111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99993136 |
112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99921178 |
113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99808045 |
114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99580668 |
115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99537626 |
116 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97641620 |
117 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95910434 |
118 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95524352 |
119 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95297783 |
120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94621183 |
121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94132653 |
122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93801936 |
123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92613612 |
124 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.92043087 |
125 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90875825 |
126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90828812 |
127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90779438 |
128 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.89319828 |
129 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89064866 |
130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88418519 |
131 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.88120527 |
132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87674510 |
133 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87079334 |
134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85608731 |
135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84270518 |
136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83987779 |
137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83848904 |
138 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.83523682 |
139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82557169 |
140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82058669 |
141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81903363 |
142 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80200653 |
143 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.78511221 |
144 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78121166 |
145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78092153 |
146 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77999828 |
147 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.77158880 |
148 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.77047296 |
149 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.76990428 |
150 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.76876557 |
151 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.75963655 |
152 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75096027 |
153 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74599440 |
154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74591589 |
155 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.74540528 |
156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73558809 |
157 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.72646106 |
158 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.72373429 |
159 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.71926004 |
160 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.71485529 |
161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70897129 |
162 | KDM2B_26808549_Chip-Seq_REH_Human | 0.70539200 |
163 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.69725827 |
164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.69440355 |
165 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66574052 |
166 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66456025 |
167 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.66354614 |
168 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.66264157 |
169 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65580476 |
170 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65225353 |
171 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65039833 |
172 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.64672663 |
173 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63949213 |
174 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63672855 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.16550860 |
2 | MP0005360_urolithiasis | 6.53076175 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.47942595 |
4 | MP0005365_abnormal_bile_salt | 5.26424272 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.08878946 |
6 | MP0003252_abnormal_bile_duct | 3.47875762 |
7 | MP0000579_abnormal_nail_morphology | 3.23507412 |
8 | MP0002796_impaired_skin_barrier | 3.12711999 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.89763684 |
10 | MP0005451_abnormal_body_composition | 2.88561646 |
11 | MP0000569_abnormal_digit_pigmentation | 2.84872088 |
12 | MP0010329_abnormal_lipoprotein_level | 2.82387844 |
13 | MP0003195_calcinosis | 2.59763866 |
14 | MP0008877_abnormal_DNA_methylation | 2.55135373 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.43692129 |
16 | MP0002254_reproductive_system_inflammat | 2.26399778 |
17 | MP0009840_abnormal_foam_cell | 2.24352363 |
18 | MP0002102_abnormal_ear_morphology | 2.22660196 |
19 | MP0005332_abnormal_amino_acid | 2.20590263 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.14065608 |
21 | MP0003787_abnormal_imprinting | 2.09333930 |
22 | MP0001666_abnormal_nutrient_absorption | 2.07993816 |
23 | MP0005671_abnormal_response_to | 2.06969466 |
24 | MP0008872_abnormal_physiological_respon | 2.05774185 |
25 | MP0003646_muscle_fatigue | 2.00865265 |
26 | MP0005645_abnormal_hypothalamus_physiol | 1.98804087 |
27 | MP0002837_dystrophic_cardiac_calcinosis | 1.96139605 |
28 | MP0004381_abnormal_hair_follicle | 1.95106521 |
29 | MP0000372_irregular_coat_pigmentation | 1.94428984 |
30 | MP0005551_abnormal_eye_electrophysiolog | 1.91592549 |
31 | MP0002138_abnormal_hepatobiliary_system | 1.91441774 |
32 | MP0001968_abnormal_touch/_nociception | 1.87313768 |
33 | MP0005083_abnormal_biliary_tract | 1.83455881 |
34 | MP0005275_abnormal_skin_tensile | 1.83150398 |
35 | MP0000383_abnormal_hair_follicle | 1.80890626 |
36 | MP0004885_abnormal_endolymph | 1.80021371 |
37 | MP0009697_abnormal_copulation | 1.77237438 |
38 | MP0002277_abnormal_respiratory_mucosa | 1.74726190 |
39 | MP0006072_abnormal_retinal_apoptosis | 1.74463774 |
40 | MP0005501_abnormal_skin_physiology | 1.74029159 |
41 | MP0005167_abnormal_blood-brain_barrier | 1.70253264 |
42 | MP0000609_abnormal_liver_physiology | 1.69947606 |
43 | MP0002098_abnormal_vibrissa_morphology | 1.67085652 |
44 | MP0009764_decreased_sensitivity_to | 1.66046476 |
45 | MP0002118_abnormal_lipid_homeostasis | 1.64648092 |
46 | MP0004043_abnormal_pH_regulation | 1.63597566 |
47 | MP0004142_abnormal_muscle_tone | 1.59123984 |
48 | MP0004947_skin_inflammation | 1.57890837 |
49 | MP0001501_abnormal_sleep_pattern | 1.56363313 |
50 | MP0009046_muscle_twitch | 1.56256988 |
51 | MP0002736_abnormal_nociception_after | 1.55647684 |
52 | MP0005253_abnormal_eye_physiology | 1.55114270 |
53 | MP0000427_abnormal_hair_cycle | 1.54564711 |
54 | MP0001986_abnormal_taste_sensitivity | 1.53979200 |
55 | MP0001216_abnormal_epidermal_layer | 1.52154519 |
56 | MP0003436_decreased_susceptibility_to | 1.50110532 |
57 | MP0000685_abnormal_immune_system | 1.49346674 |
58 | MP0002060_abnormal_skin_morphology | 1.47966563 |
59 | MP0003303_peritoneal_inflammation | 1.45179387 |
60 | MP0001764_abnormal_homeostasis | 1.44803816 |
61 | MP0005000_abnormal_immune_tolerance | 1.40946378 |
62 | MP0010678_abnormal_skin_adnexa | 1.39658079 |
63 | MP0009745_abnormal_behavioral_response | 1.38984164 |
64 | MP0000647_abnormal_sebaceous_gland | 1.38965368 |
65 | MP0003868_abnormal_feces_composition | 1.38935865 |
66 | MP0005319_abnormal_enzyme/_coenzyme | 1.36683285 |
67 | MP0005646_abnormal_pituitary_gland | 1.36352369 |
68 | MP0005075_abnormal_melanosome_morpholog | 1.35525214 |
69 | MP0002653_abnormal_ependyma_morphology | 1.35464501 |
70 | MP0002723_abnormal_immune_serum | 1.34621837 |
71 | MP0005174_abnormal_tail_pigmentation | 1.34168954 |
72 | MP0010234_abnormal_vibrissa_follicle | 1.29740201 |
73 | MP0003011_delayed_dark_adaptation | 1.28161737 |
74 | MP0000015_abnormal_ear_pigmentation | 1.26474244 |
75 | MP0002095_abnormal_skin_pigmentation | 1.24434764 |
76 | MP0000377_abnormal_hair_follicle | 1.19648296 |
77 | MP0002452_abnormal_antigen_presenting | 1.18312787 |
78 | MP0005647_abnormal_sex_gland | 1.15681319 |
79 | MP0003705_abnormal_hypodermis_morpholog | 1.14927483 |
80 | MP0003186_abnormal_redox_activity | 1.14630827 |
81 | MP0003453_abnormal_keratinocyte_physiol | 1.14463165 |
82 | MP0010771_integument_phenotype | 1.12720233 |
83 | MP0002420_abnormal_adaptive_immunity | 1.11608721 |
84 | MP0002693_abnormal_pancreas_physiology | 1.11601570 |
85 | MP0002272_abnormal_nervous_system | 1.10964332 |
86 | MP0002638_abnormal_pupillary_reflex | 1.10478638 |
87 | MP0006276_abnormal_autonomic_nervous | 1.10184014 |
88 | MP0001819_abnormal_immune_cell | 1.09490436 |
89 | MP0004782_abnormal_surfactant_physiolog | 1.08541298 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08053368 |
91 | MP0010386_abnormal_urinary_bladder | 1.03247377 |
92 | MP0001970_abnormal_pain_threshold | 1.02499562 |
93 | MP0005410_abnormal_fertilization | 1.01934296 |
94 | MP0003880_abnormal_central_pattern | 1.00587406 |
95 | MP0009643_abnormal_urine_homeostasis | 0.98744081 |
96 | MP0003724_increased_susceptibility_to | 0.98586854 |
97 | MP0002733_abnormal_thermal_nociception | 0.97507809 |
98 | MP0002876_abnormal_thyroid_physiology | 0.97488227 |
99 | MP0004742_abnormal_vestibular_system | 0.96501860 |
100 | MP0009785_altered_susceptibility_to | 0.96309063 |
101 | MP0009763_increased_sensitivity_to | 0.95040042 |
102 | MP0008469_abnormal_protein_level | 0.93510989 |
103 | MP0003878_abnormal_ear_physiology | 0.93360628 |
104 | MP0005377_hearing/vestibular/ear_phenot | 0.93360628 |
105 | MP0002735_abnormal_chemical_nociception | 0.92737740 |
106 | MP0002572_abnormal_emotion/affect_behav | 0.91100542 |
107 | MP0001486_abnormal_startle_reflex | 0.91059360 |
108 | MP0006292_abnormal_olfactory_placode | 0.90466889 |
109 | MP0002064_seizures | 0.90136800 |
110 | MP0002132_abnormal_respiratory_system | 0.90093767 |
111 | MP0005636_abnormal_mineral_homeostasis | 0.89326003 |
112 | MP0001191_abnormal_skin_condition | 0.87562294 |
113 | MP0004147_increased_porphyrin_level | 0.86966744 |
114 | MP0000467_abnormal_esophagus_morphology | 0.86925811 |
115 | MP0002405_respiratory_system_inflammati | 0.86743408 |
116 | MP0001485_abnormal_pinna_reflex | 0.85803138 |
117 | MP0005386_behavior/neurological_phenoty | 0.85065170 |
118 | MP0004924_abnormal_behavior | 0.85065170 |
119 | MP0009931_abnormal_skin_appearance | 0.82914493 |
120 | MP0005310_abnormal_salivary_gland | 0.82488885 |
121 | MP0000367_abnormal_coat/_hair | 0.81905001 |
122 | MP0001905_abnormal_dopamine_level | 0.81607708 |
123 | MP0001243_abnormal_dermal_layer | 0.81418628 |
124 | MP0000230_abnormal_systemic_arterial | 0.80645067 |
125 | MP0001346_abnormal_lacrimal_gland | 0.80159944 |
126 | MP0001835_abnormal_antigen_presentation | 0.79854383 |
127 | MP0005408_hypopigmentation | 0.79447083 |
128 | MP0003656_abnormal_erythrocyte_physiolo | 0.79328717 |
129 | MP0005464_abnormal_platelet_physiology | 0.78787331 |
130 | MP0001529_abnormal_vocalization | 0.78373618 |
131 | MP0000598_abnormal_liver_morphology | 0.78164150 |
132 | MP0001533_abnormal_skeleton_physiology | 0.76494254 |
133 | MP0001919_abnormal_reproductive_system | 0.76210412 |
134 | MP0002229_neurodegeneration | 0.75014950 |
135 | MP0002163_abnormal_gland_morphology | 0.74071341 |
136 | MP0001984_abnormal_olfaction | 0.73769588 |
137 | MP0002006_tumorigenesis | 0.73752370 |
138 | MP0005389_reproductive_system_phenotype | 0.73160496 |
139 | MP0009765_abnormal_xenobiotic_induced | 0.72342786 |
140 | MP0005025_abnormal_response_to | 0.71741410 |
141 | MP0001661_extended_life_span | 0.71421282 |
142 | MP0002148_abnormal_hypersensitivity_rea | 0.70265697 |
143 | MP0009642_abnormal_blood_homeostasis | 0.70213097 |
144 | MP0000566_synostosis | 0.68940164 |
145 | MP0002419_abnormal_innate_immunity | 0.65670400 |
146 | MP0009053_abnormal_anal_canal | 0.64198480 |
147 | MP0001845_abnormal_inflammatory_respons | 0.61852156 |
148 | MP0002928_abnormal_bile_duct | 0.60045992 |
149 | MP0002136_abnormal_kidney_physiology | 0.58186482 |
150 | MP0001790_abnormal_immune_system | 0.56363635 |
151 | MP0005387_immune_system_phenotype | 0.56363635 |
152 | MP0003718_maternal_effect | 0.56050017 |
153 | MP0005220_abnormal_exocrine_pancreas | 0.55759359 |
154 | MP0005084_abnormal_gallbladder_morpholo | 0.54613832 |
155 | MP0005248_abnormal_Harderian_gland | 0.54086113 |
156 | MP0003941_abnormal_skin_development | 0.52835742 |
157 | MP0001853_heart_inflammation | 0.52022173 |
158 | MP0000538_abnormal_urinary_bladder | 0.50790542 |
159 | MP0005395_other_phenotype | 0.50780974 |
160 | MP0002971_abnormal_brown_adipose | 0.50595271 |
161 | MP0005535_abnormal_body_temperature | 0.50372697 |
162 | MP0004264_abnormal_extraembryonic_tissu | 0.47634904 |
163 | MP0003075_altered_response_to | 0.46855707 |
164 | MP0002078_abnormal_glucose_homeostasis | 0.46206667 |
165 | MP0005334_abnormal_fat_pad | 0.46013277 |
166 | MP0008260_abnormal_autophagy | 0.45760650 |
167 | MP0003638_abnormal_response/metabolism_ | 0.45596211 |
168 | MP0006082_CNS_inflammation | 0.44681252 |
169 | MP0001188_hyperpigmentation | 0.43324312 |
170 | MP0001800_abnormal_humoral_immune | 0.43054570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.45247351 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.42505051 |
3 | Deep venous thrombosis (HP:0002625) | 6.04498903 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 5.76444770 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.53085355 |
6 | Xanthomatosis (HP:0000991) | 5.26113919 |
7 | Hypobetalipoproteinemia (HP:0003563) | 4.92219590 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.74798235 |
9 | Stomatitis (HP:0010280) | 4.54604134 |
10 | Joint hemorrhage (HP:0005261) | 4.51729216 |
11 | Complement deficiency (HP:0004431) | 4.43482220 |
12 | Pancreatic cysts (HP:0001737) | 4.04008078 |
13 | Hypolipoproteinemia (HP:0010981) | 3.93170915 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89771423 |
15 | Epidermoid cyst (HP:0200040) | 3.88007750 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 3.75179690 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67989121 |
18 | Congenital stationary night blindness (HP:0007642) | 3.64917680 |
19 | Abnormality of midbrain morphology (HP:0002418) | 3.62835628 |
20 | Molar tooth sign on MRI (HP:0002419) | 3.62835628 |
21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62529049 |
22 | Fat malabsorption (HP:0002630) | 3.59625038 |
23 | Hyperammonemia (HP:0001987) | 3.57891664 |
24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55730854 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51732386 |
26 | Pancreatic fibrosis (HP:0100732) | 3.49146261 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.43425489 |
28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41308884 |
29 | Hypotrichosis (HP:0001006) | 3.39758727 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.39173822 |
31 | Abnormality of complement system (HP:0005339) | 3.37529268 |
32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.37464274 |
33 | Hypoglycemic coma (HP:0001325) | 3.36455406 |
34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34817004 |
35 | Hyperglycinemia (HP:0002154) | 3.33042031 |
36 | Ketosis (HP:0001946) | 3.32436081 |
37 | True hermaphroditism (HP:0010459) | 3.25539405 |
38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23174483 |
39 | Attenuation of retinal blood vessels (HP:0007843) | 3.10886266 |
40 | Retrobulbar optic neuritis (HP:0100654) | 3.09708107 |
41 | Optic neuritis (HP:0100653) | 3.09708107 |
42 | Hyperglycinuria (HP:0003108) | 3.08314054 |
43 | Myocardial infarction (HP:0001658) | 3.06278471 |
44 | Palmoplantar hyperkeratosis (HP:0000972) | 3.04350496 |
45 | Abnormality of nail color (HP:0100643) | 3.03067855 |
46 | Abolished electroretinogram (ERG) (HP:0000550) | 3.02572375 |
47 | Vascular calcification (HP:0004934) | 3.01285445 |
48 | Systemic lupus erythematosus (HP:0002725) | 3.00778957 |
49 | Increased IgE level (HP:0003212) | 2.94313479 |
50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93226750 |
51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.92770627 |
52 | Abnormality of glycine metabolism (HP:0010895) | 2.92770627 |
53 | Plantar hyperkeratosis (HP:0007556) | 2.92352950 |
54 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.91197667 |
55 | Hypercholesterolemia (HP:0003124) | 2.90345494 |
56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.88918733 |
57 | Stomach cancer (HP:0012126) | 2.88855352 |
58 | Palmar hyperkeratosis (HP:0010765) | 2.87519225 |
59 | Erythroderma (HP:0001019) | 2.87415232 |
60 | Nephronophthisis (HP:0000090) | 2.87026217 |
61 | Spontaneous abortion (HP:0005268) | 2.79708956 |
62 | Renal cortical cysts (HP:0000803) | 2.79437743 |
63 | Type II lissencephaly (HP:0007260) | 2.79180481 |
64 | Steatorrhea (HP:0002570) | 2.76127466 |
65 | Hyperbilirubinemia (HP:0002904) | 2.74449279 |
66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74068456 |
67 | Myositis (HP:0100614) | 2.72444868 |
68 | Abnormality of purine metabolism (HP:0004352) | 2.71107989 |
69 | Abnormality of the renal medulla (HP:0100957) | 2.70891100 |
70 | Thick nail (HP:0001805) | 2.70717049 |
71 | Orchitis (HP:0100796) | 2.69459448 |
72 | Hypochromic microcytic anemia (HP:0004840) | 2.69169926 |
73 | Abnormality of the renal cortex (HP:0011035) | 2.68427921 |
74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68239134 |
75 | Cardiovascular calcification (HP:0011915) | 2.63689962 |
76 | Pendular nystagmus (HP:0012043) | 2.60867565 |
77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59453673 |
78 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.55361309 |
79 | Woolly hair (HP:0002224) | 2.54224368 |
80 | Alopecia of scalp (HP:0002293) | 2.51698985 |
81 | Onycholysis (HP:0001806) | 2.47486404 |
82 | Gangrene (HP:0100758) | 2.46235633 |
83 | Medial flaring of the eyebrow (HP:0010747) | 2.44914695 |
84 | Mitral stenosis (HP:0001718) | 2.44211546 |
85 | Hyperventilation (HP:0002883) | 2.43550781 |
86 | Keratoconjunctivitis (HP:0001096) | 2.40119799 |
87 | Gingival bleeding (HP:0000225) | 2.36265153 |
88 | Dicarboxylic aciduria (HP:0003215) | 2.35936006 |
89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35936006 |
90 | Hepatocellular carcinoma (HP:0001402) | 2.35453400 |
91 | Delayed CNS myelination (HP:0002188) | 2.35396306 |
92 | Erythema (HP:0010783) | 2.32272111 |
93 | Decreased central vision (HP:0007663) | 2.31799563 |
94 | Hypoglycemic seizures (HP:0002173) | 2.31545137 |
95 | Furrowed tongue (HP:0000221) | 2.30400937 |
96 | Inability to walk (HP:0002540) | 2.29378009 |
97 | Hypothermia (HP:0002045) | 2.28643460 |
98 | Progressive inability to walk (HP:0002505) | 2.28558381 |
99 | Ketoacidosis (HP:0001993) | 2.27235609 |
100 | Eczematoid dermatitis (HP:0000976) | 2.27210935 |
101 | Gaze-evoked nystagmus (HP:0000640) | 2.26054487 |
102 | Lissencephaly (HP:0001339) | 2.24090595 |
103 | Gout (HP:0001997) | 2.23901137 |
104 | Metabolic acidosis (HP:0001942) | 2.23157712 |
105 | Abnormality of serum amino acid levels (HP:0003112) | 2.22747716 |
106 | Large for gestational age (HP:0001520) | 2.22227027 |
107 | Right ventricular cardiomyopathy (HP:0011663) | 2.16026275 |
108 | Neonatal onset (HP:0003623) | 2.15853133 |
109 | Abnormal drinking behavior (HP:0030082) | 2.15326537 |
110 | Polydipsia (HP:0001959) | 2.15326537 |
111 | Menorrhagia (HP:0000132) | 2.12334118 |
112 | Keratoconjunctivitis sicca (HP:0001097) | 2.11521585 |
113 | Generalized aminoaciduria (HP:0002909) | 2.10413655 |
114 | Episodic fever (HP:0001954) | 2.07848475 |
115 | Constricted visual fields (HP:0001133) | 2.07076679 |
116 | Chronic hepatic failure (HP:0100626) | 2.05316590 |
117 | Abnormal gallbladder morphology (HP:0012437) | 2.05228397 |
118 | Pili torti (HP:0003777) | 2.04121759 |
119 | * Pruritus (HP:0000989) | 2.03002294 |
120 | Agitation (HP:0000713) | 2.02577927 |
121 | Abnormality of proline metabolism (HP:0010907) | 2.00459962 |
122 | Hydroxyprolinuria (HP:0003080) | 2.00459962 |
123 | Keratoconus (HP:0000563) | 2.00165168 |
124 | Increased corneal curvature (HP:0100692) | 2.00165168 |
125 | Encephalitis (HP:0002383) | 1.99670444 |
126 | Amyloidosis (HP:0011034) | 1.99281737 |
127 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98976248 |
128 | Hemiparesis (HP:0001269) | 1.98634962 |
129 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98213529 |
130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97602005 |
131 | Cystic liver disease (HP:0006706) | 1.97263287 |
132 | Enlarged kidneys (HP:0000105) | 1.96310907 |
133 | Optic disc pallor (HP:0000543) | 1.95084510 |
134 | Progressive macrocephaly (HP:0004481) | 1.94532078 |
135 | Cholelithiasis (HP:0001081) | 1.93429531 |
136 | Oral leukoplakia (HP:0002745) | 1.93340587 |
137 | Parakeratosis (HP:0001036) | 1.93314259 |
138 | Acute necrotizing encephalopathy (HP:0006965) | 1.92161372 |
139 | Tubular atrophy (HP:0000092) | 1.91874910 |
140 | Abnormality of macular pigmentation (HP:0008002) | 1.91327303 |
141 | Acanthocytosis (HP:0001927) | 1.90770422 |
142 | Malnutrition (HP:0004395) | 1.89979254 |
143 | Glomerulonephritis (HP:0000099) | 1.89963022 |
144 | Lethargy (HP:0001254) | 1.89662525 |
145 | Recurrent bacterial skin infections (HP:0005406) | 1.89579126 |
146 | Fair hair (HP:0002286) | 1.89003379 |
147 | Abnormal biliary tract physiology (HP:0012439) | 1.88512760 |
148 | Bile duct proliferation (HP:0001408) | 1.88512760 |
149 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88410248 |
150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88337077 |
151 | Keratitis (HP:0000491) | 1.87959263 |
152 | Widely spaced teeth (HP:0000687) | 1.87725605 |
153 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.87612172 |
154 | Rickets (HP:0002748) | 1.87347120 |
155 | Thrombophlebitis (HP:0004418) | 1.87323600 |
156 | Conjunctival hamartoma (HP:0100780) | 1.87292482 |
157 | Symptomatic seizures (HP:0011145) | 1.86998001 |
158 | Hypophosphatemic rickets (HP:0004912) | 1.86765913 |
159 | Thyroiditis (HP:0100646) | 1.86415076 |
160 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85621713 |
161 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85621713 |
162 | Absent speech (HP:0001344) | 1.84366525 |
163 | Mitochondrial inheritance (HP:0001427) | 1.84166336 |
164 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.83694607 |
165 | Absent/shortened dynein arms (HP:0200106) | 1.83694607 |
166 | Hypomagnesemia (HP:0002917) | 1.83623922 |
167 | Broad-based gait (HP:0002136) | 1.82323433 |
168 | Febrile seizures (HP:0002373) | 1.81744894 |
169 | Generalized hypopigmentation of hair (HP:0011358) | 1.81199027 |
170 | Polyuria (HP:0000103) | 1.81133329 |
171 | Abnormality of the labia minora (HP:0012880) | 1.80508179 |
172 | Increased CSF lactate (HP:0002490) | 1.79340713 |
173 | Congenital hepatic fibrosis (HP:0002612) | 1.78814277 |
174 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75175687 |
175 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74693764 |
176 | Pachygyria (HP:0001302) | 1.74669680 |
177 | Intestinal atresia (HP:0011100) | 1.73175356 |
178 | Hyperalaninemia (HP:0003348) | 1.73017846 |
179 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73017846 |
180 | Abnormality of alanine metabolism (HP:0010916) | 1.73017846 |
181 | Methylmalonic acidemia (HP:0002912) | 1.72981751 |
182 | Gait imbalance (HP:0002141) | 1.71526040 |
183 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69508649 |
184 | Focal motor seizures (HP:0011153) | 1.68569560 |
185 | Photophobia (HP:0000613) | 1.67160530 |
186 | Recurrent fungal infections (HP:0002841) | 1.65833309 |
187 | Congenital primary aphakia (HP:0007707) | 1.65423197 |
188 | Acute encephalopathy (HP:0006846) | 1.64866689 |
189 | Chorioretinal atrophy (HP:0000533) | 1.62699664 |
190 | Vacuolated lymphocytes (HP:0001922) | 1.62418044 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 3.70767214 |
2 | ERN1 | 3.69805996 |
3 | INSRR | 3.38414258 |
4 | BCKDK | 3.22154039 |
5 | PIK3CG | 3.18944439 |
6 | MAP4K2 | 2.99548075 |
7 | FGFR4 | 2.85510391 |
8 | STK38L | 2.59680557 |
9 | TAOK3 | 2.50304205 |
10 | ERBB4 | 2.49152933 |
11 | SIK1 | 2.48338148 |
12 | BMPR1B | 2.36107594 |
13 | FRK | 2.34022819 |
14 | LATS1 | 2.32024489 |
15 | MAP3K14 | 2.17068275 |
16 | ZAK | 2.15252556 |
17 | ACVR1B | 1.97677362 |
18 | EPHA3 | 1.86750847 |
19 | TYK2 | 1.80922560 |
20 | TRPM7 | 1.78318621 |
21 | MAPK13 | 1.76093782 |
22 | TBK1 | 1.64089225 |
23 | TRIM28 | 1.62152221 |
24 | WNK4 | 1.62062913 |
25 | IRAK3 | 1.58426980 |
26 | TLK1 | 1.55248692 |
27 | AKT3 | 1.55170112 |
28 | CASK | 1.53027462 |
29 | MAPK11 | 1.47044203 |
30 | BLK | 1.43159456 |
31 | IKBKE | 1.41060768 |
32 | MAPKAPK3 | 1.38553949 |
33 | STK24 | 1.38440981 |
34 | OXSR1 | 1.34480617 |
35 | EIF2AK3 | 1.34212285 |
36 | MAP3K3 | 1.33526648 |
37 | EIF2AK2 | 1.30850555 |
38 | MAP3K4 | 1.29327495 |
39 | MAP2K4 | 1.27374517 |
40 | TNK2 | 1.27137066 |
41 | ERBB3 | 1.24421948 |
42 | MET | 1.24089766 |
43 | SGK2 | 1.20879311 |
44 | TNIK | 1.19729731 |
45 | PAK3 | 1.17487389 |
46 | SIK3 | 1.16189366 |
47 | FLT3 | 1.16159203 |
48 | PRKAA2 | 1.13991346 |
49 | TXK | 1.11597563 |
50 | ADRBK1 | 1.10393929 |
51 | JAK1 | 1.10370159 |
52 | MAP3K6 | 1.09341836 |
53 | GRK1 | 1.08738249 |
54 | EPHA2 | 1.07632998 |
55 | KIT | 1.04586791 |
56 | STK3 | 1.03116990 |
57 | CAMKK2 | 1.00297107 |
58 | PTK2B | 0.99007742 |
59 | DYRK2 | 0.95265430 |
60 | MAP3K7 | 0.89860550 |
61 | JAK2 | 0.88589125 |
62 | DAPK2 | 0.88116754 |
63 | MAPK15 | 0.87781021 |
64 | CSNK1G2 | 0.85138043 |
65 | MAP2K7 | 0.84949969 |
66 | TGFBR1 | 0.84792000 |
67 | FES | 0.83856603 |
68 | SGK3 | 0.83801381 |
69 | PRKCE | 0.83595176 |
70 | NUAK1 | 0.82546110 |
71 | MAP2K6 | 0.82196527 |
72 | JAK3 | 0.81412765 |
73 | NTRK3 | 0.81199608 |
74 | TEC | 0.79523185 |
75 | BCR | 0.79421058 |
76 | WNK3 | 0.78501988 |
77 | NEK9 | 0.78196232 |
78 | CSNK1G3 | 0.77569021 |
79 | ITK | 0.77324544 |
80 | PINK1 | 0.77171265 |
81 | CHUK | 0.75642906 |
82 | CSK | 0.74896131 |
83 | BRAF | 0.74601776 |
84 | VRK1 | 0.74027091 |
85 | RIPK1 | 0.72722645 |
86 | CSNK1G1 | 0.72577771 |
87 | IKBKB | 0.72176094 |
88 | GRK6 | 0.70873581 |
89 | PBK | 0.70139448 |
90 | MATK | 0.69904600 |
91 | MARK1 | 0.68371810 |
92 | PKN1 | 0.66823343 |
93 | BMPR2 | 0.66075221 |
94 | MAP4K1 | 0.65287128 |
95 | PHKG2 | 0.65110540 |
96 | PHKG1 | 0.65110540 |
97 | STK39 | 0.62941320 |
98 | MAP3K13 | 0.61609512 |
99 | ABL2 | 0.59868256 |
100 | IRAK4 | 0.59867178 |
101 | CSNK1A1L | 0.59656440 |
102 | MAPK7 | 0.59448473 |
103 | YES1 | 0.59024443 |
104 | MKNK2 | 0.58741187 |
105 | FGFR2 | 0.57517163 |
106 | BTK | 0.57018063 |
107 | STK11 | 0.56621350 |
108 | PLK2 | 0.56438145 |
109 | SYK | 0.56085837 |
110 | FER | 0.55155057 |
111 | MST4 | 0.54727497 |
112 | RPS6KA4 | 0.53790324 |
113 | NME1 | 0.53628731 |
114 | EIF2AK1 | 0.51588296 |
115 | STK16 | 0.50678944 |
116 | PRKAA1 | 0.50450414 |
117 | CDK3 | 0.49947713 |
118 | SGK223 | 0.49265299 |
119 | SGK494 | 0.49265299 |
120 | TAOK1 | 0.49094680 |
121 | LCK | 0.48852459 |
122 | HCK | 0.47247893 |
123 | MAPK4 | 0.46439920 |
124 | TGFBR2 | 0.46111489 |
125 | PRKCG | 0.45469410 |
126 | TIE1 | 0.44974727 |
127 | FGFR3 | 0.43971540 |
128 | TAOK2 | 0.42896837 |
129 | MAP3K11 | 0.42597431 |
130 | PIK3CA | 0.42330938 |
131 | PRKCI | 0.42209392 |
132 | ADRBK2 | 0.41886768 |
133 | PRKACG | 0.41759355 |
134 | PTK6 | 0.40091593 |
135 | RIPK4 | 0.39265642 |
136 | MAP3K5 | 0.38841999 |
137 | IRAK1 | 0.38822351 |
138 | CAMK1D | 0.38365806 |
139 | CAMK1 | 0.38287484 |
140 | CAMK2A | 0.38092304 |
141 | RPS6KA5 | 0.37700232 |
142 | PTK2 | 0.37688821 |
143 | PRKCQ | 0.37423831 |
144 | PLK3 | 0.37073765 |
145 | CSF1R | 0.37038948 |
146 | PRKCZ | 0.36899584 |
147 | GRK7 | 0.36647043 |
148 | LYN | 0.36398625 |
149 | PRKACA | 0.36340767 |
150 | NLK | 0.36250652 |
151 | ZAP70 | 0.36232046 |
152 | CAMK4 | 0.35151979 |
153 | MAPK12 | 0.35003845 |
154 | PRKCD | 0.34462850 |
155 | MAP2K3 | 0.34227556 |
156 | DYRK1B | 0.33832756 |
157 | ERBB2 | 0.33784083 |
158 | ABL1 | 0.31785844 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45254589 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21593423 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13904423 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87569743 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76396263 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73565984 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58750143 |
8 | Phototransduction_Homo sapiens_hsa04744 | 2.48704519 |
9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.41262171 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38667680 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34699551 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.28998713 |
13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.26742563 |
14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.25726250 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23242074 |
16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.22641938 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20171455 |
18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19018011 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.14346618 |
20 | Peroxisome_Homo sapiens_hsa04146 | 2.13842273 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11314718 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 2.10704215 |
23 | Retinol metabolism_Homo sapiens_hsa00830 | 2.07505154 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01628375 |
25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.01222432 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00027119 |
27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99961178 |
28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95932786 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94695907 |
30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.78552938 |
31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75858745 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74580168 |
33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.73187174 |
34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72305331 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.71757564 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67459332 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66674093 |
38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65475973 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61335883 |
40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60962944 |
41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60209203 |
42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56980122 |
43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56551266 |
44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56247719 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.53531434 |
46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.49761307 |
47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47108126 |
48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47060084 |
49 | Protein export_Homo sapiens_hsa03060 | 1.45633760 |
50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43582004 |
51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41051635 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35337934 |
53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33795490 |
54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30230157 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29660909 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29282115 |
57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27585721 |
58 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27473661 |
59 | Bile secretion_Homo sapiens_hsa04976 | 1.25922835 |
60 | Homologous recombination_Homo sapiens_hsa03440 | 1.24653527 |
61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21713809 |
62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21339416 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20390097 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18980282 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11647701 |
66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11191398 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09425451 |
68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09423609 |
69 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08396850 |
70 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03605160 |
71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00296173 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97631813 |
73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96706080 |
74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96201078 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95650981 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94434435 |
77 | Tuberculosis_Homo sapiens_hsa05152 | 0.94369166 |
78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93462217 |
79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89305540 |
80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87720084 |
81 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87308333 |
82 | Morphine addiction_Homo sapiens_hsa05032 | 0.85613348 |
83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84094299 |
84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82299229 |
85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78281286 |
86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75196153 |
87 | Proteasome_Homo sapiens_hsa03050 | 0.73895970 |
88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73697420 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.72346836 |
90 | Taste transduction_Homo sapiens_hsa04742 | 0.71737404 |
91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70270950 |
92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69513120 |
93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65959599 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65928124 |
95 | RNA polymerase_Homo sapiens_hsa03020 | 0.65657194 |
96 | Salivary secretion_Homo sapiens_hsa04970 | 0.65620529 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65529430 |
98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63551868 |
99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62068244 |
100 | RNA degradation_Homo sapiens_hsa03018 | 0.60919231 |
101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58652866 |
102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58591707 |
103 | Insulin secretion_Homo sapiens_hsa04911 | 0.57798307 |
104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57051548 |
105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56590587 |
106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53388303 |
107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52517702 |
108 | Measles_Homo sapiens_hsa05162 | 0.51649946 |
109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50958630 |
110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48507412 |
111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48017728 |
112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47592190 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.46291740 |
114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45018074 |
115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44648995 |
116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42492476 |
117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42438447 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42341812 |
119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40341804 |
120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40224078 |
121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39961800 |
122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39761149 |
123 | Long-term depression_Homo sapiens_hsa04730 | 0.39756974 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39450623 |
125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36550193 |
126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31404735 |
127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28538610 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22825621 |
129 | Prion diseases_Homo sapiens_hsa05020 | 0.21076707 |
130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.19412352 |
131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15990778 |
132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.15524396 |
133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15206780 |
134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14922511 |
135 | Insulin resistance_Homo sapiens_hsa04931 | 0.14876790 |
136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13415813 |
137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.12965632 |
138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12408599 |
139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.09732343 |
140 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.08088506 |
141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07082407 |
142 | Legionellosis_Homo sapiens_hsa05134 | 0.06132346 |
143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.05627037 |
144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05296762 |
145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05143655 |
146 | Pertussis_Homo sapiens_hsa05133 | 0.03279703 |
147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03117984 |
148 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.03019658 |
149 | Hepatitis C_Homo sapiens_hsa05160 | 0.01417761 |
150 | Malaria_Homo sapiens_hsa05144 | 0.00946044 |
151 | Asthma_Homo sapiens_hsa05310 | 0.00807744 |
152 | Amoebiasis_Homo sapiens_hsa05146 | -0.0241755 |
153 | Phagosome_Homo sapiens_hsa04145 | -0.0150047 |
154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0133729 |